This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moyer, J. D. Articles by Handschumacher, R. E. Search for Related Content PubMed PubMed Citation Articles by Moyer, J. D. Articles by Handschumacher, R. E.

Salvage of Circulating Pyrimidine Nucleosides in the Rat¹

Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510 [J. D. M., R. E. H.], and Boehringer Ingelheim Research and Development Center, Ridgefield, Connecticut 06877 [J. T. O.]

A new procedure was developed to measure uridine and cytidine in plasma. These nucleosides are present in micromolar concentrations in the plasma of rats, mice, and humans. Inhibitors of pyrimidine synthesis de novo (pyrazofurin or N-phosphonacetyl-L-aspartate) produce only modest decreases in the concentration of circulating uridine or cytidine in the rat. Since both uridine and cytidine are rapidly cleared from the circulation of the rat, constant infusions of radiolabeled uridine and cytidine were used to establish a steady-state specific activity of circulating nucleoside without altering the normal endogenous concentration. These studies permitted an estimation of the contribution of circulating pyrimidine nucleoside to the nucleotide pools of various rat tissues. Most of the uridine entering the circulation (>70%) is catabolized rather than salvaged by formation of nucleotides. Cytidine in the circulation is much more efficiently utilized and is predominantly salvaged. The implication of these results for chemotherapy based on inhibition of pyrimidine synthesis de novo is discussed.

¹ Supported by American Cancer Society Grant CH-67T.

² To whom requests for reprints should be addressed.

Received 1/19/81. Accepted 4/22/81.

This article has been cited by other articles:

				F. Rodriguez-Serrano, J. A. Marchal, A. Rios, A. Martinez-Amat, H. Boulaiz, J. Prados, M. Peran, O. Caba, E. Carrillo, F. Hita, et al. Exogenous Nucleosides Modulate Proliferation of Rat Intestinal Epithelial IEC-6 Cells J. Nutr., April 1, 2007; 137(4): 879 - 884. [Abstract] [Full Text] [PDF]

				M. J. Saez-Lara, M. Manzano, A. J. Angulo, A. Suarez, M. I. Torres, C. Gomez-Llorente, A. Gil, and L. Fontana Exogenous Nucleosides Stimulate Proliferation of Fetal Rat Hepatocytes J. Nutr., June 1, 2004; 134(6): 1309 - 1313. [Abstract] [Full Text] [PDF]

				Y. Zhang, J. J. Repa, Y. Inoue, G. P. Hayhurst, F. J. Gonzalez, and D. J. Mangelsdorf Identification of a Liver-Specific Uridine Phosphorylase that Is Regulated by Multiple Lipid-Sensing Nuclear Receptors Mol. Endocrinol., April 1, 2004; 18(4): 851 - 862. [Abstract] [Full Text] [PDF]

				M. P. Liu, L. Beigelman, E. Levy, R. E. Handschumacher, and G. Pizzorno Discrete roles of hepatocytes and nonparenchymal cells in uridine catabolism as a component of its homeostasis Am J Physiol Gastrointest Liver Physiol, June 1, 1998; 274(6): G1018 - G1023. [Abstract] [Full Text] [PDF]

				X. Xu, J. W. Williams, J. Shen, H. Gong, D.-P. Yin, L. Blinder, R. T. Elder, H. Sankary, A. Finnegan, and A. S.-F. Chong In Vitro and In Vivo Mechanisms of Action of the Antiproliferative and Immunosuppressive Agent, Brequinar Sodium J. Immunol., January 15, 1998; 160(2): 846 - 853. [Abstract] [Full Text] [PDF]

				T Gasser, J. Moyer, and R. Handschumacher Novel single-pass exchange of circulating uridine in rat liver Science, August 14, 1981; 213(4509): 777 - 778. [Abstract] [PDF]